QuickCool AB (publ) The European Patent Office considers significant component patentable

The European Patent Office announced on 20 September 2018 that it considers QuickCool’s patent application via PCT (Patent Cooperation Treaty), concerning one of the significant components of QuickCool’s portable cooling device for Targeted Temperature Management (TTM) QuickCool® SYSTEM, patentable.

QuickCool has previously been granted the equivalent patent in Sweden. The positive opinion may contribute constructively in the patent process in several of the countries where QuickCool intends to apply for patents.

QuickCool collaborates with AWA Sweden AB when it comes to Intellectual Property (IP) related issues.

For further information, please contact:
Fredrik Radencrantz, VD
Telefon: 046-286 38 40
E-post: fredrik.radencrantz@quickcool.se

Quickcool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (Inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the Quickcool SYSTEM. Quickcool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool’s solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool’s Intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. Quickcool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to: www.quickcool.se

Tags: